Table 1 Overview of process and outcome indicators hip and knee replacements and breast cancer

Total Hip and Knee replacements *

S

P

O

% of patients that was administered thrombosis prophylaxis for 6 weeks to 3 months post-surgery, in case of total hip or knee surgery

X

% of patients that did not (2008 & 2009)/ did (2010) receive a homologue blood transfusion, in case of total hip or knee surgery

X

% of patients that was administered antibiotics perioperatively

X

% of patients that was administered antibiotics 15 to 60 min. prior to surgery or to blood emptiness

X

% of patients with a deep wound infection after a total hip or knee replacement

X

Breast Cancer **

S

P

O

% of patients who were seen by a breast cancer nurse specialist preoperatively

X

% of patients that was reviewed preoperatively in a multi-disciplinary team meeting

X

% of patients with a non-radical primary tumor resection

X

% of surgeons in the surgery department that perform surgical treatments of breast tumors

X

% of patients that are operated within 4 weeks after the final lab results are known

X

% of patients with local recurrences within 5 years after breast-conserving surgery

X

% of patients that have local recurrences within 5 years after ablative breast surgery

X

% of patients with a breast tumor that was postoperatively reviewed in a documented multi-disciplinary team meeting

X